Apricot kernel oil
CAS 72869-69-3
Apricot kernel oil (CAS 72869-69-3) is a pharmaceutical compound with 0 bioactivity targets and 2 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Apricot kernel oil is linked to DTXSID40893039 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| APRICOT KERNEL OIL | 1318515 | SU | MTHSPL |
| apricot kernel oil | 1318515 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Apricot kernel oil used for in pharmaceutical contexts?
Apricot kernel oil (CAS 72869-69-3) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Apricot kernel oil?
Apricot kernel oil has 2 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Therapeutic response decreased, Tumour marker increased. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Apricot kernel oil also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Paeonia Lactiflora Root Extract with EU status "permitted".
What clinical phase is Apricot kernel oil in?
No phase 1-4 clinical development badge is rendered for Apricot kernel oil because the matched compound identifier rows do not contain a max-phase value.